260 related articles for article (PubMed ID: 11920288)
1. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.
Goldstein ST; Alter MJ; Williams IT; Moyer LA; Judson FN; Mottram K; Fleenor M; Ryder PL; Margolis HS
J Infect Dis; 2002 Mar; 185(6):713-9. PubMed ID: 11920288
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
3. Incidence of acute hepatitis B--United States, 1990-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Jan; 52(51-52):1252-4. PubMed ID: 14704650
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for acute viral hepatitis--United States, 2006.
Wasley A; Grytdal S; Gallagher K;
MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
[TBL] [Abstract][Full Text] [Related]
5. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
6. Surveillance for acute viral hepatitis--United States, 2005.
Wasley A; Miller JT; Finelli L;
MMWR Surveill Summ; 2007 Mar; 56(3):1-24. PubMed ID: 17363893
[TBL] [Abstract][Full Text] [Related]
7. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
Mele A; Mariano A; Tosti ME; Stroffolini T; Pizzuti R; Gallo G; Ragni P; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2007 Feb; 44(3):e17-24. PubMed ID: 17205431
[TBL] [Abstract][Full Text] [Related]
8. Acute hepatitis B among children and adolescents--United States, 1990-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1015-8. PubMed ID: 15525899
[TBL] [Abstract][Full Text] [Related]
9. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
10. Two community hepatitis B outbreaks: an argument for vaccinating incarcerated persons.
Devasia RA; Jones TF; Kainer MA; Halford S; Sheeler LL; Swift J; Schaffner W
Vaccine; 2006 Feb; 24(9):1354-8. PubMed ID: 16297510
[TBL] [Abstract][Full Text] [Related]
11. Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients.
Rosner G; Lurie Y; Blendis L; Halpern Z; Oren R
Postgrad Med J; 2006 Mar; 82(965):207-10. PubMed ID: 16517803
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B vaccination coverage among adults--United States, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 May; 55(18):509-11. PubMed ID: 16691181
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B and C risk factors in Germany--results of the national surveillance].
Walter J; Radun D; Claus H; Hamouda O; Stark K
Gesundheitswesen; 2005 Jul; 67(7):441-7. PubMed ID: 16103966
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis B in Poland in 2007].
Rosińska M; Czarkowski MP
Przegl Epidemiol; 2009; 63(2):245-50. PubMed ID: 19799254
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
Mele A; Stroffolini T; Zanetti AR
J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hepatitis B virus infection.
Mahoney FJ; Burkholder BT; Matson CC
Am Fam Physician; 1993 Mar; 47(4):865-74. PubMed ID: 8438685
[TBL] [Abstract][Full Text] [Related]
18. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
Oldfield EC; Keeffe EB
Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
[TBL] [Abstract][Full Text] [Related]
19. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B vaccination and changes in sexual risk behaviour among men who have sex with men in Amsterdam.
Xiridou M; Wallinga J; Dukers-Muijers N; Coutinho R
Epidemiol Infect; 2009 Apr; 137(4):504-12. PubMed ID: 18631424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
